Colitis-associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy.
Mai IwayaHiroyuki HayashiTomoyuki NakajimaKazuyuki MatsudaYasuhiro KinugawaYosuke TobeYoko TateishiYugo IwayaTakeshi UeharaHiroyoshi OtaPublished in: Histopathology (2021)
These findings suggest that certain CAC cases may be candidates for targeted zolbetuximab therapy.